Lake elmo bank11.02.2019
All of LifeCycle Pharmas product candidates are based on the companys MeltDose technology, which is particularly lake elmo bank to create new and improved versions of existing drugs. By applying the MeltDose technology to improve the efficacy of well-known and valuable drugs, we believe that we are able to develop products significantly faster and cheaper and with a higher lake elmo bank rate compared to the development of completely new drugs.
We believe, that the MeltDose technology may not only improves the efficacy of drugs. By enhancing the absorption of drugs in the body, we believe that the technology may also be used to reduce the side effects associated with such medication. LifeCycle Pharma is building its success on:.
The most advanced product candidate has completed pivotal clinical studies and an application for market authorization has been submitted to the US FDA earlier this year. All of LifeCycle Pharmas product candidates are based on the companys MeltDose technology, which is particularly suited to create new laake improved versions of existing drugs.